FDA 483 - Beal G. Essink, MD - November 06, 2014

An FDA inspection of Beal G. Essink, MD in Portland, OR, a clinical investigator, revealed two significant observations. The firm failed to ensure unused investigational drug supplies were returned to the sponsor. Additionally, the inspection found a failure to prepare and maintain accurate case histories, with numerous discrepancies between source documents and case report forms.